Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China

prnasiaMay 14, 2021

Tag: Antengene , Eltanexor , Solid Tumors

PharmaSources Customer Service